PRESS-RELEASE ·Filed Jul 8, 2026

PHGE

BiomX
NEUTRAL
Impact 4/10
Horizonmonths Processed2mo ago WireGlobeNewswire
Press release: m_and_a
Actionable Insight • Neutral

The LOI is non-binding and uncertain. Monitor for definitive agreement, financing details, and NYSE American compliance. If closed, the acquisition could transform BiomX's operational scale but carries significant integration and funding risk.

DirectionNeutral
Confidencelow
Horizonmonths
Latest settled — T+20d
PHGE ▼ -34.74% at T+20d
NEUTRAL call ✗ call lost -34.74% · α vs SPY -38.01% · entry $0.2758 → $0.1800
Next anchor: T+60d due yesterday
Latest observation: T+53 +149.93% FF3 residual α
Entry anchored
Jul 7, 03:59 PM ET
via exchange tick
T+1d
+1.52%
call +1.52% · α +0.68%
$0.2800
settled 3mo ago
T+5d
-23.86%
call -23.86% · α -24.72%
$0.2100
settled 3mo ago
T+20d
-34.74%
call -34.74% · α -38.01%
$0.1800
settled 8w ago
T+60d
—
call — · α —
—
due yesterday

Price Chart

Loading chart...

Executive Summary

BiomX announced a non-binding LOI to acquire 60% of Tsoock Defense Technologies for $10.4M, payable mostly in quarterly installments. Tsoock, an Israeli security integrator, had ~$3.5M revenue and ~$168K net profit in 2025. The deal is highly uncertain, subject to due diligence, financing, and approvals. Given BiomX's $4M market cap and going-concern qualification, this represents a significant but risky strategic move.

Key Financial Metrics

Deal Value
$10.4M

Key Facts

  • Non-binding LOI to acquire 60% of Tsoock Defense Technologies for $10.4M total consideration.
  • Tsoock generated ~NIS 13.1M ($3.5M) revenue in 2025, up 70% YoY, with net profit of ~NIS 625K ($168K).
  • Initial payment of $300,000; remaining $10.1M in four quarterly installments over 12 months.
  • Option to acquire remaining 40% for $9.2M within 36 months post-closing.
  • BiomX has a $4M market cap and a going-concern qualification in its SEC filings.

Financial Impact

Deal value of $10.4M represents ~260% of BiomX's market cap, with most consideration deferred. Tsoock's 2025 revenue of ~$3.5M would more than double BiomX's current revenue (if any).

revenuedebtdilution

Risk Factors

  • Non-binding LOI may not lead to definitive agreement.
  • Financing risk: BiomX has going-concern qualification and small market cap.
  • Regulatory approvals required, including SEC and NYSE American.
  • Integration of Tsoock's operations may be challenging.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3323967
20 reports for PHGE
Performance horizon
64% Hit rate 7 of 11 directional calls best @ T+20▲ +62.36%Jun 16, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1425 $1.85▲ +1198.25%▲ +1199.20%$0.3600 (+152.63%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.1371 $0.1550▲ +13.06%▲ +13.20%$0.3600 (+162.58%)
Aug 5, 2026
8w ago
Press Release
BEARISH ★ 5/10
$0.1800 $0.1483▲ +17.61%▲ +17.96%$0.3600 (−100.00%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 27, 2026
9w ago
424B5
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.2758 $0.2100▼ −23.86%▼ −24.72%$0.3600 (+30.53%)
Jul 2, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.3190 $0.2800▲ +12.23%▲ +13.16%$0.3600 (−12.85%)
Jun 29, 2026
13w ago
S-1
BEARISH ★ 5/10
$0.3478 $0.3020▲ +13.17%▲ +13.77%$0.3600 (−3.51%)
Jun 22, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4615 $0.3590▼ −22.21%▼ −23.22%$0.3600 (−21.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (33h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 8, 2026